Severely obese youths who received exenatide injections twice a day for three months lost about seven pounds more than the placebo group, according to a study in JAMA Pediatrics. Initially approved by the FDA for adults with type 2 diabetes, exenatide showed potential "in terms of weight reduction and cardiovascular risk control," lead author Aaron Kelly said.
Diabetes drug for adults may help obese youths lose weight
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|